Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Concordia International (CXRXF)

Concordia International (CXRXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Concordia International 85 KING WILLIAM STREET LONDON X0 EC4N 7BL GBR

www.advanzpharma.com P: 44-20-8588-9100

Description:

Advanz Pharma Corp. is a specialty pharmaceutical company. It operates primarily in Bridgetown, Barbados; London, England and Mumbai, through its subsidiaries. Advanz Pharma Corp., formerly known as Concordia International Corp., is based in LONDON, UNITED KINGDOM.

Key Statistics

Overview:

Market Capitalization, $K 834,456
Shares Outstanding, K 48,913
Annual Sales, $ 525,580 K
Annual Net Income, $ -74,860 K
Last Quarter Sales, $ 136,110 K
Last Quarter Net Income, $ -15,240 K
% of Institutional Shareholders 0.00%
Float, K 48,913
% Float 100.00%

Growth:

1-Year Return 394.49%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 33.32%
5-Year Earnings Growth -99.86%
5-Year Dividend Growth -100.00%

Per-Share Information:

Latest Earnings Date 05/12/21
Earnings Per Share ttm -1.38
EPS Growth vs. Prev Qtr 11.43%
EPS Growth vs. Prev Year -72.22%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-300 on 09/11/18

CXRXF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -4.38%
Profit Margin % -14.24%
Debt/Equity 257.04
Price/Sales 1.57
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.10
Interest Coverage -0.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar